window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biomanufacturing

  • Biomanufacturing,Technology and platforms

    AnalytiChem UK highlights microbial EM products at Pharmig 2025

    AnalytiChem UK (formerly Cherwell) will showcase its range of environmental [...]

    November 12, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Facilities and infrastructure,Technology and platforms

    AES Cleanroom Technology opens new office in Research Triangle Park to expand Southeast presence

    AES Cleanroom Technology has opened a new regional office in [...]

    November 12, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Partnerships & Funding,Technology and platforms

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    November 6, 2025
  • Biologics & Biosimilars,Biomanufacturing,Biotech,CDMOs & Manufacturing,Clinical Development,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    November 5, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics

    NurExone joins ARMI BioFab Startup Lab to boost US regenerative manufacturing

    NurExone Biologic Inc has been accepted into the BioFab Startup [...]

    November 5, 2025
  • Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CDMO Argonaut appoints Rick Hancock to drive next phase of biologics and commercial manufacturing

    Argonaut Manufacturing Services has named Rick Hancock as chief executive [...]

    November 5, 2025
  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Biomanufacturing,Cell & Gene Therapy,Clinical Development,Rare Diseases,Regulatory Affairs

    Imlifidase enables gene therapy for Crigler–Najjar patients with AAV immunity

    Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

    October 12, 2025
  • Biomanufacturing,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    Grifols’ Biotest launches Yimmugo in United States after FDA approval

    Grifols has expanded its portfolio of plasma-derived therapies in the [...]

    October 12, 2025
  • Biomanufacturing,Clinical Trials,European biotech,Pharmaceuticals and therapeutics,Regulatory Affairs,Supply Chain & Logistics

    Klifo receives regulatory approval for new clinical trial supply facility in Copenhagen

    KLIFO, Europe’s largest independent provider of clinical trial supply (CTS) [...]

    October 9, 2025
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top